Inventor
LAI HUNG-SEN
US37 patents
⚠️ This page may combine multiple inventors who share the name “LAI HUNG-SEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TUFTS COLLEGE
23 patentsUS7994121B2Aug 9, 2011
Stable analogs of peptide and polypeptide therapeutics
TUFTS COLLEGE16 citations91
US7259234B2Aug 21, 2007
Stable analogs of peptide and polypeptide therapeutics
TUFTS COLLEGE25 citations91
US11096924B2Aug 24, 2021
Combination therapies using immuno-dash inhibitors and PGE2 antagonists
TUFTS COLLEGE6 citations84
US10517955B2Dec 31, 2019
FAP-activated proteasome inhibitors for treating solid tumors
TUFTS COLLEGE9 citations84
US9956297B2May 1, 2018
FAP-activated proteasome inhibitors for treating solid tumors
TUFTS COLLEGE10 citations84
US8933056B2Jan 13, 2015
Soft protease inhibitors and pro-soft forms thereof
TUFTS COLLEGE5 citations84
US8889720B2Nov 18, 2014
Non-flushing niacin analogues, and methods of use thereof
TUFTS COLLEGE4 citations84
US7998997B2Aug 16, 2011
Inhibitors of fibroblast activation protein alpha
TUFTS COLLEGE7 citations84
US10245248B2Apr 2, 2019
FAP-activated therapeutic agents, and uses related thereto
TUFTS COLLEGE5 citations83
US10117887B2Nov 6, 2018
FAP-activated therapeutic agents, and uses related thereto
TUFTS COLLEGE6 citations83
US9737556B2Aug 22, 2017
FAP-activated therapeutic agents, and uses related thereto
TUFTS COLLEGE8 citations83
US11957657B2Apr 16, 2024
Combination therapies using immuno-dash inhibitors and PGE2 antagonists
TUFTS COLLEGE2 citations73
US11583516B2Feb 21, 2023
Dash inhibitors, and uses related thereto
TUFTS COLLEGE3 citations73
US11559537B2Jan 24, 2023
Combination therapies using caspase-1 dependent anticancer agents and PGE2 antagonists
TUFTS COLLEGE2 citations73
US11065339B2Jul 20, 2021
FAP-activated proteasome inhibitors for treating solid tumors
TUFTS COLLEGE1 citations73
US9511060B2Dec 6, 2016
Non-flushing niacin analogues, and methods of use thereof
TUFTS COLLEGE1 citations63
US9193708B2Nov 24, 2015
Non-flushing niacin analogues, and methods of use thereof
TUFTS COLLEGE2 citations63
US8377971B2Feb 19, 2013
Non-flushing niacin analogues, and methods of use thereof
TUFTS COLLEGE2 citations63
US12478609B2Nov 25, 2025
Combination therapies using immuno-DASH inhibitors and PGE2 antagonists
TUFTS COLLEGE0 citations62
US12214047B2Feb 4, 2025
FAP-activated proteasome inhibitors for treating solid tumors
TUFTS COLLEGE0 citations62
US11707539B2Jul 25, 2023
FAP-targeted radiopharmaceuticals and imaging agents, and uses related thereto
TUFTS COLLEGE0 citations62
US9212142B2Dec 15, 2015
Niacin mimetics, and methods of use thereof
TUFTS COLLEGE2 citations60
US9192646B2Nov 24, 2015
Soft protease inhibitors and pro-soft forms thereof
TUFTS COLLEGE0 citations52
BACHOVCHIN WILLIAM W
7 patentsUS9597410B2Mar 21, 2017
FAP-activated proteasome inhibitors for treating solid tumors
BACHOVCHIN WILLIAM W16 citations92
US8268880B2Sep 18, 2012
Soft protease inhibitors and pro-soft forms thereof
BACHOVCHIN WILLIAM W9 citations84
US8937063B2Jan 20, 2015
Niacin mimetics, and methods of use thereof
BACHOVCHIN WILLIAM W3 citations59
US8450316B2May 28, 2013
Niacin mimetics, and methods of use thereof
BACHOVCHIN WILLIAM W2 citations57
US8563533B2Oct 22, 2013
Soft protease inhibitors and pro-soft forms thereof
BACHOVCHIN WILLIAM W0 citations52
US8513187B2Aug 20, 2013
Soft protease inhibitors, and pro-soft forms thereof
BACHOVCHIN WILLIAM W0 citations52
US9102756B2Aug 11, 2015
Stable analogs of peptide and polypeptide therapeutics
BACHOVCHIN WILLIAM W0 citations50
BACH BIOSCIENCES LLC
7 patentsUS11266669B2Mar 8, 2022
FAP-activated therapeutic agents, and uses related thereto
BACH BIOSCIENCES LLC4 citations82
US10709722B2Jul 14, 2020
FAP-activated therapeutic agents, and uses related thereto
BACH BIOSCIENCES LLC5 citations82
US11033525B2Jun 15, 2021
Fap-activated therapeutic agents, and uses related thereto
BACH BIOSCIENCES LLC1 citations71
US12121505B2Oct 22, 2024
Fap-activated therapeutic agents, and uses related thereto
BACH BIOSCIENCES LLC0 citations61
US12053450B2Aug 6, 2024
FAP-activated therapeutic agents, and uses related thereto
BACH BIOSCIENCES LLC0 citations61
US12023316B2Jul 2, 2024
FAP-activated therapeutic agents, and uses related thereto
BACH BIOSCIENCES LLC0 citations61
US11925655B2Mar 12, 2024
FAP-activated therapeutic agents, and uses related thereto
BACH BIOSCIENCES LLC0 citations61